Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Initially approved for the treatment of type 2 diabetes, some GLP-1 drugs later received regulatory approval for managing obesity in people with a high body mass index (BMI)
An earlier analysis evaluating MEDVi's positioning as a GLP-1 supplier heading into 2026 examines the platform's pricing structure, operational transparency, and compounded semaglutide access model within the broader telehealth market
2014;9:e92676
That study used intraperitoneal dosing in mice and rats and cannot be directly translated to subcutaneous dosing in human adolescents
US$ 29.19
US$ 21.36
US$ 26.38
